drugset / Trial / NCT00862381
Hydrocortisone Use After Etomidate in Intensive Care
RandomizedParallel-groupQuadruple-blindTreatment
Summary
the objective of the study is to assess the value of substitution with 200mg/24h of hydrocortisone for 48 hours for patients in intensive care who have received a single injection of etomidate
Timeline
- Start
- 2008-10
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrocortisone | Other / unclassified | 200 mg | Other |
Indications
No indication recorded.